Hanmi Pharmaceutical has exported a new drug candidate, which it licensed from a U.S. company six years ago, to a Chinese corporation.This is the first time that Hanmi Pharmaceutical has exported a new drug technology acquired from outside.Hanmi Pharmaceutical announced on Jan. 3 that it signed a co
POSCO International, the trading arm of POSCO Group, is pushing to establish a motor core plant in Eastern Europe. Motor cores are a key component of electric vehicles that generates electricity.POSCO International and POSCO SPS, a 100 percent subsidiary of the trading company that produces motor co
EOFlow Co., a Korean pharmaceutical company specializing in wearable drug delivery solutions, announced on Dec. 28 that its wholly owned U.S. subsidiary, EOFlow Inc. has signed an agreement to establish a joint venture in the U.S. with the U.K. biotech firm Zihipp Limited, a spin-off from Imperial C
LegoChem Biosciences has licensed out an anti-cancer drug candidate to a British pharmaceutical company in a deal worth up to 1.12 trillion won (US$944.3 million), the Korean biotech company announced on Dec. 27.LegoChem will receive US$50 million in down payment and technology fees, and up to US$1
Ultium Cells, a electric vehicle battery joint venture established by LG Energy Solution and General Motors (GM), is considering investing US$2.5 billion to build a new battery plant near a GM auto assembly plant in Lansing, Michigan. If the plan is finalized, it will be the third joint venture plan
SK Bioscience announced on Dec. 21 that it has started a project to develop a general-purpose vaccine that can respond to both the COVID-19 virus and its variants such as Omicron and Delta. To this end, it will receive US$50 million in initial R&D expenses from the Coalition for Epidemic Preparednes
The authors are economists of Shinhan Investment Corp. They can be reached at heekim@shinhan.com. – Ed. EU extends suspension of SGP; expansionary stance likely to continueThe EU has once again extended the suspension of the Stability and Growth Pact (SGP) for another year. The decision indicates th
Financial Services Commission Chairman Koh Seung-beom remarked again that the short selling ban in the South Korean stock market needs to be lifted. “The current partial ban needs to be lifted in the end, and we are seeking the best timing and method,” he said.Koh made the remark as the South Korean
The authors are analysts of Shinhan Investment Corp. They can be reached at shawn1225@shinhan.com and sehunjang@shinhan.com, respectively. – Ed. Strong competitive edge in rapidly-growing global ADC marketLegoChem Biosciences is leading the market for antibody-drug conjugates (ADCs) with its next-ge
Samsung Biologics has forged a partnership with GreenLight Biosciences, a U.S. biotechnology company, to manufacture the latter's messenger RNA COVID-19 vaccine candidate at commercial scale.GreenLight Biosciences is dedicated to making ribonucleic acid (RNA) products affordable and accessible f
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on Nov. 21 that South Korean pharmaceutical and biotech companies’ technology exports since the beginning of this year are 11.4049 trillion won in total.According to the association, the figure including undisclosed contract
The Independent School District (ISD) of Taylor City in Williamson County, Texas, has recently approved an incentive package to attract Samsung Electronics’ US$1.7 billion chipmaking plant.Taylor ISD trustees decided on Nov. 15 (U.S. local time) to give a total of US$292 million in tax reduction inc
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on Nov. 18 that South Korean pharmaceutical and biotech companies’ annual technology exports topped 10 trillion won for the second consecutive year.“This year, they signed 28 technology export contracts worth a total of 11.3
Samsung Electronics vice chairman Lee Jae-yong left for Canada and the United States on Nov. 14. It marks Lee's first overseas business trip since his release from prison on parole on Aug. 13 and his first business trip to the United States since 2016. Lee is expected to finalize the selection o
The author is an analyst of NH Investment & Securities. He can be reached at minjae.lee@nhqv.com. -- Ed. MOLIT is aiming to strengthen the publicness of urban redevelopment projects by limiting the upper limit of the private profit rate to 10%. At this juncture, it is difficult to predict the mid/lo
Standigm Inc., a workflow artificial intelligence (AI) drug discovery company, announced on Nov. 8 that the company has established a synthetic research center in the headquarters of SK Chemicals Co., a life science and green chemicals company.Standigm has dramatically improved the R&D productivity
HLB announced on Nov. 8 that its oral cancer drug candidate "Rivoceranib" has been designated as an orphan drug for liver cancer treatment by the U.S. Food and Drug Administration (FDA) on Nov. 4.The FDA operates the Orphan Drug Designation (ODD) program to support the development of orphan drugs.Or
The South Korean government and some local politicians are claiming that South Korea should become a part of the MSCI World Index. Under the circumstances, short selling is drawing attention. This is because the current partial short selling ban must be lifted for South Korea to become a part of the
The author is an analyst of NH Investment & Securities. He can be reached at jaemin.ahn@nhqv.com. -- Ed. Despite some platform industry regulatory concerns, we expect Kakao to enjoy brisk earnings growth in 2022, noting that earnings at its major businesses are continuing to grow rapidly. We positiv
Korea Aerospace Industries (KAI) has signed an industrial cooperation agreement with Slovakia's state-run defense company Letecke Opravovne Trencin (LOTN) to promote exports of the FA-50 fighter to the Central European country.The business agreement was signed by the presidents of both KAI and L